Evolution of monoclonal antibodies in multiple myeloma

Affiliations

Comment

Pellegrino Musto. Lancet Oncol. 2018 Dec.

. 2018 Dec;19(12):1554-1555.

doi: 10.1016/S1470-2045(18)30647-8. Epub 2018 Nov 12.

¹ IRCCS-CROB, Referral Cancer Center of Basilicata, 85028 Rionero in Vulture, Italy. Electronic address: pellegrino.musto@crob.it.

No abstract available

Comment on

Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial.
Trudel S, Lendvai N, Popat R, Voorhees PM, Reeves B, Libby EN, Richardson PG, Anderson LD Jr, Sutherland HJ, Yong K, Hoos A, Gorczyca MM, Lahiri S, He Z, Austin DJ, Opalinska JB, Cohen AD. Trudel S, et al. Lancet Oncol. 2018 Dec;19(12):1641-1653. doi: 10.1016/S1470-2045(18)30576-X. Epub 2018 Nov 12. Lancet Oncol. 2018. PMID: 30442502 Free PMC article. Clinical Trial.